logo

Azurrx Biopharma, Inc. (AZRX)



Trade AZRX now with
  Date
  Headline
9/14/2021 10:56:48 AM AzurRx BioPharma Shares Gain 14%
9/13/2021 6:15:07 AM AzurRx BioPharma Agrees To Buy First Wave Bio In Stock And Cash Transaction Valued At $229 Mln
9/10/2021 8:36:15 AM AzurRx BioPharma Activates New Clinical Trial Sites In India For Phase 2 RESERVOIR Trial Of FW-1022
9/9/2021 8:40:29 AM AzurRx BioPharma Announces Positive Data From Part 1 Of RESERVOIR Phase 2 Trial Of Niclosamide
9/8/2021 8:39:34 AM AzurRx BioPharma Submits IND Application For Niclosamide
5/13/2021 7:10:35 AM AzurRx BioPharma Announces Positive Interim Data In Phase 2 Clinical Trial Of MS1819 In Combination With PERT
3/22/2021 7:20:54 AM AzurRx BioPharma Reports Completion Of Enrollment In Phase 2 Clinical Trial Of MS1819 Plus PERT
2/24/2021 7:04:22 AM AzurRx Appoints James Sapirstein, President And CEO, As Chairman Of Board
1/21/2021 8:05:16 AM AzurRx Says First Two Patients Dosed In Phase 2b OPTION 2 Extension Study Of MS1819
8/17/2020 8:12:48 AM AzurRx BioPharma Begins European Arm Of Phase 2b OPTION 2 Clinical Trial Of MS1819
8/13/2020 8:15:54 AM AzurRx BioPharma Enrolls First 3 Patients Dosed In Phase 2b OPTION 2 Clinical Trial Of MS1819 In Cystic Fibrosis
8/13/2020 8:15:30 AM AzurRx Says First Patients Dosed In Phase 2b OPTION 2 Clinical Trial Of MS1819